Dilated Cardiomyopathy clinical trials
15 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)
- A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
- Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
- A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
- ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
- Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
- An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
- UIC Multi-Ethnic DCM Registry
- Impella Reverse Remodeling in End-Stage Heart Failure
- Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
- Study of the Progression of Chronic Cardiovascular Conditions
- AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
- Mayo AVC Registry and Biobank
- Pediatric Cardiomyopathy Mutation Analysis
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Dilated Cardiomyopathy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.